Pharmaceutical Research Transparency Act of 2022
Latest action · Apr 7, 2022 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 7, 2022
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmaceutical Research Transparency Act of 2022
This bill requires the disclosure of costs associated with clinical trials and pharmaceutical research and development.
Specifically, the National Institutes of Health must create a publicly available repository of cost data from certain clinical trials that test the efficacy of drugs, biological products, and devices in human subjects. For each applicable trial, the registry must, among other information, include the total and per patient cost of the trial, as well as costs for personnel, health care services, and other categories of expenditures. Information must be added to the registry within one year of the trial's completion.
The bill also requires drug manufacturers to include their research and development expenditures for drugs and biological products in annual disclosures made to the Securities and Exchange Commission.
Cosponsors 2
Members who signed on, in the order they did. Signatures ran from Apr 7, 2022 to Nov 14, 2022; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MN | Tina Smith | Original | Apr 7, 2022 |
| D-MN | Amy Klobuchar | Nov 14, 2022 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Apr 7, 2022 |
Actions 2
Everything that happened, newest first.
- Apr 7, 2022Introduced in Senate
- Apr 7, 2022Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 1476 | Pharmaceutical Research Transparency Act of 2023 | Reintroduced Bill | May 9, 2023 |
| HR 4747 | Open Translation and Analysis Center Authorization Act | Identical bill | Aug 4, 2021 |
| HR 7474 | Pharmaceutical Research Transparency Act of 2022 | Identical bill | Apr 8, 2022 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend the Public Health Service Act to increase the transparency of pharmaceutical research costs, and for other purposes.
- Short Title(s) as Introduced
- Pharmaceutical Research Transparency Act of 2022
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 7, 2022Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.